Home/Filings/4/0001209191-18-023747
4//SEC Filing

Knudten Andrew F. 4

Accession 0001209191-18-023747

CIK 0001652923other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:57 PM ET

Size

19.9 KB

Accession

0001209191-18-023747

Insider Transaction Report

Form 4
Period: 2018-04-02
Knudten Andrew F.
SrVP/Manufacture&Supply Chain
Transactions
  • Sale

    Common Stock

    2018-04-02$117.01/sh373$43,64510,427 total
  • Sale

    Common Stock

    2018-04-02$118.58/sh403$47,78810,024 total
  • Sale

    Common Stock

    2018-04-02$119.77/sh808$96,7749,216 total
  • Sale

    Common Stock

    2018-04-02$120.42/sh84$10,1159,132 total
  • Sale

    Common Stock

    2018-04-02$123.37/sh79$9,7468,800 total
  • Exercise/Conversion

    Common Stock

    2018-04-02$18.17/sh+2,000$36,34010,800 total
  • Sale

    Common Stock

    2018-04-02$122.19/sh253$30,9148,879 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2018-04-022,000141,800 total
    Exercise: $18.17Exp: 2025-08-11Common Stock (2,000 underlying)
Footnotes (8)
  • [F1]These sales were effected pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person on August 29, 2017.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.90 to $117.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.03 to $119.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.40 to $120.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.41 to $120.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.95 to $122.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4.
  • [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.97 to $123.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (7) to this Form 4.
  • [F8]Immediately exercisable. 37,950 shares vested and became exercisable on August 11, 2016; the remaining shares will vest and become exercisable in 36 equal monthly installments thereafter until August 11, 2019, subject to the Reporting Person's continuous service with the Issuer on each such date.

Issuer

AveXis, Inc.

CIK 0001652923

Entity typeother

Related Parties

1
  • filerCIK 0001665593

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:57 PM ET
Size
19.9 KB